Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)
Clinical trial NCT02160782 · COMPLETED
Trial details
- NCT number
- NCT02160782
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-28
- Primary completion
- 2020-05-28
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.